Merck Return on Investment 2010-2024 | MKKGY
Current and historical return on investment (ROI) values for Merck (MKKGY) over the last 10 years.
| Merck ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-06-30 |
$3.60B |
$39.24B |
9.10% |
| 2024-03-31 |
$3.81B |
$38.97B |
9.60% |
| 2023-12-31 |
$3.91B |
$38.96B |
9.91% |
| 2023-09-30 |
$4.14B |
$41.18B |
10.64% |
| 2023-06-30 |
$4.32B |
$39.55B |
11.32% |
| 2023-03-31 |
$4.51B |
$37.99B |
11.97% |
| 2022-12-31 |
$4.71B |
$37.09B |
12.76% |
| 2022-09-30 |
$5.00B |
$37.87B |
13.71% |
| 2022-06-30 |
$4.99B |
$37.69B |
14.05% |
| 2022-03-31 |
$5.00B |
$35.10B |
14.49% |
| 2021-12-31 |
$4.94B |
$35.12B |
14.46% |
| 2021-09-30 |
$4.47B |
$34.05B |
13.53% |
| 2021-06-30 |
$4.60B |
$33.84B |
15.42% |
| 2021-03-31 |
$3.88B |
$33.74B |
13.32% |
| 2020-12-31 |
$3.41B |
$30.62B |
11.93% |
| 2020-09-30 |
$3.27B |
$21.11B |
11.51% |
| 2020-06-30 |
$2.58B |
$30.95B |
8.45% |
| 2020-03-31 |
$2.74B |
$31.70B |
9.25% |
| 2019-12-31 |
$2.37B |
$29.75B |
8.45% |
| 2019-09-30 |
$2.16B |
$29.80B |
7.80% |
| 2019-06-30 |
$2.06B |
$27.06B |
7.67% |
| 2019-03-31 |
$1.83B |
$25.81B |
6.81% |
| 2018-12-31 |
$2.04B |
$28.24B |
7.49% |
| 2018-09-30 |
$1.98B |
$26.09B |
7.50% |
| 2018-06-30 |
$2.47B |
$27.41B |
9.38% |
| 2018-03-31 |
$2.69B |
$27.09B |
10.55% |
| 2017-12-31 |
$2.86B |
$24.98B |
11.52% |
| 2017-09-30 |
$2.99B |
$25.69B |
12.02% |
| 2017-06-30 |
$2.68B |
$24.11B |
10.97% |
| 2017-03-31 |
$2.61B |
$24.34B |
10.59% |
| 2016-12-31 |
$2.75B |
$25.30B |
11.15% |
| 2016-09-30 |
$2.64B |
$24.08B |
10.77% |
| 2016-06-30 |
$2.53B |
$25.02B |
10.15% |
| 2016-03-31 |
$2.46B |
$24.08B |
10.08% |
| 2015-12-31 |
$2.10B |
$24.94B |
8.62% |
| 2015-09-30 |
$1.88B |
$25.79B |
8.10% |
| 2015-06-30 |
$1.81B |
$22.99B |
8.44% |
| 2015-03-31 |
$1.76B |
$23.76B |
8.71% |
| 2014-12-31 |
$1.83B |
$20.42B |
9.75% |
| 2014-09-30 |
$2.26B |
$18.51B |
12.26% |
| 2014-06-30 |
$2.52B |
$18.04B |
13.66% |
| 2014-03-31 |
$2.88B |
$18.04B |
15.64% |
| 2013-12-31 |
$2.88B |
$19.03B |
15.57% |
| 2013-09-30 |
$5.99B |
$18.62B |
32.93% |
| 2013-06-30 |
$5.76B |
$18.07B |
42.57% |
| 2013-03-31 |
$4.97B |
$18.33B |
55.13% |
| 2012-12-31 |
$7.60B |
$17.72B |
171.58% |
| 2012-09-30 |
$7.27B |
|
inf% |
| 2012-06-30 |
$10.25B |
|
inf% |
| 2012-03-31 |
$10.32B |
|
inf% |
| 2011-12-31 |
$10.55B |
|
inf% |
| 2011-09-30 |
$10.95B |
|
inf% |
| 2011-06-30 |
$7.98B |
|
inf% |
| 2011-03-31 |
$10.53B |
|
inf% |
| 2010-12-31 |
$9.81B |
|
inf% |
| 2010-09-30 |
$9.09B |
|
inf% |
| 2010-06-30 |
$11.25B |
|
inf% |
| 2010-03-31 |
$11.14B |
|
inf% |
| 2009-12-31 |
$10.81B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
